Children’s Minnesota testing vaccine against deadly pediatric brain cancer
The trial involves a peptide developed by Minneapolis-based biotech startup OX2 Therapeutics.
The trial involves a peptide developed by Minneapolis-based biotech startup OX2 Therapeutics.